Discussion Body protection compound (BPC, M.W
Experts said there was a general lack of evidence, effectiveness and safety information about the use of BPC-157
The FDA has announced a two-day public meeting of its Pharmacy Compounding Advisory Committee (PCAC) on July 2324, 2026, to formally evaluate whether seven bulk drug substances should be added to the Section 503A Bulk Drug Substances List (the 503A Bulks List)
The ability of hydroxocobalamin to rapidly scavenge and detoxify cyanide by chelation has resulted in several acute animal and human studies using systemic hydroxocobalamin doses at suprapharmacological doses as high as 140 mg/kg to support its use as an intravenous (IV) treatment for cyanide exposure
He sustained the injury after performing deadlifts and was not able to heal following numerous massage and electric therapy sessions
Our pharmacy network partners perform third party testing through FDA and DEA registered labs to run quality control checks for every compounded lot prescribed for Helimeds patients